Clene Inc.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis … Read more
Clene Inc. (CLNN) - Total Liabilities
Latest total liabilities as of September 2025: $34.67 Million USD
Based on the latest financial reports, Clene Inc. (CLNN) has total liabilities worth $34.67 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Clene Inc. - Total Liabilities Trend (2018–2024)
This chart illustrates how Clene Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Clene Inc. Competitors by Total Liabilities
The table below lists competitors of Clene Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Megasoft Limited
NSE:MEGASOFT
|
India | ₹242.03 Million |
|
Shih Kuen Plastics Co Ltd
TWO:4305
|
Taiwan | NT$219.75 Million |
|
SYN prop e tech S.A.
SA:SYNE3
|
Brazil | R$954.80 Million |
|
BIDV Securities JSC
VN:BSI
|
Vietnam | ₫11.10 Trillion |
|
Wayi International Digital Entertainment Co
TWO:3086
|
Taiwan | NT$31.83 Million |
|
Kenorland Minerals Ltd
OTCQX:KLDCF
|
USA | $13.21 Million |
|
Ion Electronic Materials Co., Ltd.
TWO:6959
|
Taiwan | NT$788.97 Million |
|
Tirupati Forge Limited
NSE:TIRUPATIFL
|
India | ₹472.53 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Clene Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Clene Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Clene Inc. (2018–2024)
The table below shows the annual total liabilities of Clene Inc. from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $36.19 Million | -7.08% |
| 2023-12-31 | $38.95 Million | -5.59% |
| 2022-12-31 | $41.26 Million | -18.25% |
| 2021-12-31 | $50.47 Million | -25.68% |
| 2020-12-31 | $67.90 Million | +579.70% |
| 2019-12-31 | $9.99 Million | -76.31% |
| 2018-12-31 | $42.16 Million | -- |